Driven by looming patent cliffs, newly buoyant public markets, and Big Pharma's race to beef up their pipelines, dealmaking ...

Shares of Krystal Biotech KRYS have risen 16% over the past three months against the industry’s 9.4% decline, driven by ...

If enacted, lawmakers will hold the right to monitor and restrict American companies from signing certain deals with Chinese ...

Buy Legend Biotech (LEGN): new Carvykti CARTITUDE-4 data show better survival and <1% Parkinsonism; upside at 3.0x ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

A proposal to add biotechnology to the COINS Act follows two big deals involving Pfizer and Bristol Myers, and comes amid U.S ...

In 2023, ReNAgade Therapeutics launched with $300 million to exploit an “all in one” technology solution for RNA-based therapies. That same year, Tome Biosciences emerged from stealth with $213 ...

In early June 2026, Legend Biotech reported early Phase 1 data for LB2501 in relapsed/refractory B-cell non-Hodgkin lymphoma, showing high response rates, durable in vivo CAR-T expansion without ...

The drug industry has been working on how to shuttle drugs through the blood-brain barrier, and the results will become apparent this year. These large-cap companies could be poised to join the ...

Government backing, deep scientific talent and a robust pharma heritage are helping France punch above its weight, but ...

NewLimit’s lead liver combo has proven its worth in preclinical models, Kimmel told Fierce, with the ability to boost ...

If you’re looking to diversify outside of AI, especially as AI investors look to trim their winners to save up for that ...